138 related articles for article (PubMed ID: 23125008)
1. Expression of beclin 1 in bladder cancer and its clinical significance.
Liu GH; Zhong Q; Ye YL; Wang HB; Hu LJ; Qin ZK; Zeng MS; Zeng BH
Int J Biol Markers; 2013 Apr; 28(1):56-62. PubMed ID: 23125008
[TBL] [Abstract][Full Text] [Related]
2. PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer.
Yun SJ; Jo SW; Ha YS; Lee OJ; Kim WT; Kim YJ; Lee SC; Kim WJ
Urol Oncol; 2012; 30(6):893-9. PubMed ID: 21396842
[TBL] [Abstract][Full Text] [Related]
3. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
[TBL] [Abstract][Full Text] [Related]
4. Bromodomain 4 protein is a predictor of survival for urothelial carcinoma of bladder.
Yan Y; Yang FQ; Zhang HM; Li J; Li W; Wang GC; Che JP; Zheng JH; Liu M
Int J Clin Exp Pathol; 2014; 7(7):4231-8. PubMed ID: 25120803
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer.
Ruan J; Wei B; Xu Z; Yang S; Zhou Y; Yu M; Liang J; Jin K; Huang X; Lu P; Cheng H
Med Oncol; 2013 Mar; 30(1):445. PubMed ID: 23307254
[TBL] [Abstract][Full Text] [Related]
6. CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.
Xue Y; Wu G; Wang X; Zou X; Zhang G; Xiao R; Yuan Y; Long D; Yang J; Wu Y; Xu H; Liu F; Liu M
Med Oncol; 2013 Mar; 30(1):406. PubMed ID: 23275123
[TBL] [Abstract][Full Text] [Related]
7. Association of low expression of notch-1 and jagged-1 in human papillary bladder cancer and shorter survival.
Shi TP; Xu H; Wei JF; Ai X; Ma X; Wang BJ; Ju ZH; Zhang GX; Wang C; Wu ZQ; Zhang X
J Urol; 2008 Jul; 180(1):361-6. PubMed ID: 18499162
[TBL] [Abstract][Full Text] [Related]
8. Association of elevated HIF-2α levels with low Beclin 1 expression and poor prognosis in patients with chondrosarcoma.
Chen C; Ma Q; Ma X; Liu Z; Liu X
Ann Surg Oncol; 2011 Aug; 18(8):2364-72. PubMed ID: 21327823
[TBL] [Abstract][Full Text] [Related]
9. Argonaute 2 is up-regulated in tissues of urothelial carcinoma of bladder.
Yang FQ; Huang JH; Liu M; Yang FP; Li W; Wang GC; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(1):340-7. PubMed ID: 24427355
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder.
Liu JY; Li YH; Lin HX; Liao YJ; Mai SJ; Liu ZW; Zhang ZL; Jiang LJ; Zhang JX; Kung HF; Zeng YX; Zhou FJ; Xie D
BMC Cancer; 2013 Jul; 13():349. PubMed ID: 23870412
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer.
Ye J; Zhang Y; Cai Z; Jiang M; Li B; Chen G; Zeng Y; Liang Y; Wu S; Wang Z; He H; Zhong W; Wu CL
BMC Urol; 2018 Sep; 18(1):82. PubMed ID: 30249226
[TBL] [Abstract][Full Text] [Related]
12. Expression of Bmi-1 is a prognostic marker in bladder cancer.
Qin ZK; Yang JA; Ye YL; Zhang X; Xu LH; Zhou FJ; Han H; Liu ZW; Song LB; Zeng MS
BMC Cancer; 2009 Feb; 9():61. PubMed ID: 19228380
[TBL] [Abstract][Full Text] [Related]
13. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
[TBL] [Abstract][Full Text] [Related]
14. Beclin 1 and its emerging role as a prognostic biomarker in systemic malignancies besides bladder carcinomas.
Kapoor S
Int J Biol Markers; 2013 Apr; 28(1):113. PubMed ID: 23558941
[No Abstract] [Full Text] [Related]
15. Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer.
Lin YL; Wang YL; Fu XL; Li WP; Wang YH; Ma JG
Oncotarget; 2016 May; 7(19):28384-92. PubMed ID: 27070091
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer.
Wang Y; Zhu Z; Zeng F; Wang L; Wu Y; Xia W; Xing S
J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):444-7. PubMed ID: 17828507
[TBL] [Abstract][Full Text] [Related]
17. Low expression of TMEM67 is a critical predictor of poor prognosis in human urothelial carcinoma of the bladder.
Du E; Zhang C; Qin Z; Yang K; Li C; Wang A; Zhang Z; Xu Y
Urol Oncol; 2017 Apr; 35(4):152.e7-152.e12. PubMed ID: 28161324
[TBL] [Abstract][Full Text] [Related]
18. High expression of Cdc25B and low expression of 14-3-3σ is associated with the development and poor prognosis in urothelial carcinoma of bladder.
Zhang Z; Zhang G; Kong C
Tumour Biol; 2014 Mar; 35(3):2503-12. PubMed ID: 24234332
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.
Boman K; Segersten U; Ahlgren G; Eberhard J; Uhlén M; Jirström K; Malmström PU
BMC Urol; 2013 Apr; 13():17. PubMed ID: 23565664
[TBL] [Abstract][Full Text] [Related]
20. Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma.
Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
Immunobiology; 2015 Jan; 220(1):68-73. PubMed ID: 25214475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]